The goal shouldnt just be to lose weightyou also want to feel great and maintain long-term results
Gastrointestinal Very common (10% or more): Nausea (up to 18%), diarrhea (up to 17%) Common (1% to 10%): Vomiting, constipation, dyspepsia, abdominal pain, eructation, flatulence, gastroesophageal reflux disease, abdominal distension Uncommon (0.1% to 1%): Cholelithiasis, acute pancreatitis, increased serum pancreatic amylase levels, increased serum lipase levels, acute gallbladder disease (including cholelithiasis, biliary colic and cholecystectomy) Postmarketing reports : Ileus In pooled placebo-controlled trials, treatment with this drug resulted in mean increases from baseline in serum pancreatic amylase levels of up to 38% and serum lipase levels of up to 42%
Rated 5 out of 5 Anonymous (verified owner) Verified review - view original Rated 5 out of 5 Anonymous (verified owner) Verified review - view original I have been on tirzepatide through Citizen Meds for just under a year now and absolutely love it
Semaglutide is known as a GLP-1 receptor agonist
This is where the 1.0 mL syringe loses precision compared to smaller sizes
